Table 2.
MicroRNA | mechanism | CeRNA | Physiological context | Cancer |
---|---|---|---|---|
miR-216b | 3′UTR | proliferationb, invasionb | Glioblastoma [113], melanoma [114], hepatocellular carcinoma [115] | |
MiR-214 | 3′UTR | proliferationb, invasionb, drug sensitivitya | cervical cancer [54] | |
miR-361-5p | 3′UTR | proliferationb, invasionb | lung cancer [116] | |
miR-342 | 3′UTR | proliferationb, migrationb | colorectal cancer [117] | |
miR-671-5p | 3′UTR | proliferationb,invasionb,EMTb | breast cancer [118] | |
miR-149 | 3′UTR | drug sensitivitya, EMTb | Colorectal Cancer [55], non-small cell lung cancer [119] | |
miR-509-5p | 3′UTR | proliferationb, migrationb, invasionb | non-small cell lung cancer [120] | |
miR-802 | 3′UTR | proliferationb | breast cancer [121] | |
miR-34a | 3′UTR | CCAT2 [58] | senescencea | hepatocellular carcinoma [122] |
miR-370 | 3′UTR | proliferationb,apoptosisa | osteosarcoma [123], laryngeal squamous cell carcinoma [124], gastric carcinoma [125] | |
miR-877 | 3′UTR | proliferationb | hepatocellular carcinoma [126] | |
miR-320 | 3′UTR | drug sensitivitya, radiosensitivitya | colon cancer [127], Glioma [128] | |
miR-204 | 3′UTR | invasionb, EMTb | esophageal cancer [129] | |
miR-24-1 | 3′UTR | proliferationb | bladder cancer [130] | |
miR-342-3p | 3′UTR | H19 [57] | proliferationb, migrationb, invasionb | cervical cancer [56] |
a: promoting
b: Inhibition